Development of non-invasive biomarker discovery and diagnostics approach for bladder cancer based on urine proteome and phosphoproteome
Ended Project Grant Awarded Last action
- Award ID
- R44CA239845
- Recipient
-
Tymora Analytical Operations LLC UEI ZFFZKDYTF5Q9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,924,999
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Funding
-
- $2,224,999.00 Federal
- $700,000.00 Non-federal
- Place of performance
- West Lafayette, IN, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $700,000 | $0 | |
| Amendment | $700,000 | $700,000 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $600,000 | $0 | |
| Original award | $224,999 | $0 |
Quick answers
Who received award R44CA239845?
R44CA239845 was awarded to Tymora Analytical Operations LLC by National Cancer Institute (National Institutes of Health) on September 1, 2019.
How much is award R44CA239845 worth?
$2,924,999 has been obligated on R44CA239845: $2,224,999 in federal funding and $700,000 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award